

EH SafeTI Lancet
Designed for simple and safe capillary sampling
Overview
Integrated Automatic Inactivation System
How to Use
Overview

Safety
- Integrated automatic inactivation system to prevent lancet reuse
- Needles retract immediately after use to reduce te risk of needle stick injuries
Minimum Pain
- Ultra-sharp Tri-bevel needle and high speed penetration to reduce pain
- Double spring to control puncture depth and firing force for blood sampling with less pain
Easy To Use
- Ergonomically designed for easy handling
- T-shaped design for easier grip and activation
Highly Stable Performance
- Ensure adequate blood collected each time
- Strict quality control to ensure appropriate incision depth and adequate blood flow
Integrated Automatic Inactivation System
Integrated Automatic Inactivation System

Sharps injury prevention feature
There is an integrated automatic inactivation system to prevent lancet reuse. The needle retracts automatically back into the housing after the puncture, due to the force from the pressed front spring. The needle cannot go back to the starting position and stays between the relaxed rear spring and front spring. Therefore, the device cannot be re-used.
How to Use
How to Use

Get the free CONTOUR®DIABETES App here:



*95% of the measured glucose values needed to fall within either ±0.83 mmol/L (±15 mg/dL) of the average measured values of the reference measurement procedure at glucose concentrations <5.55 mmol/L (<100 mg/dL) or within ±15% at glucose concentrations ≥5.55 mmol/L (≥100 mg/dL). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.3
**On a compatible Android or iOS device. For a list of compatilbe operating systems, please visit compatibility.contourone.com
**On a compatible Android or iOS device. For a list of compatilbe operating systems, please visit compatibility.contourone.com
- CONTOUR®PLUS ONE BGMS User Guide Rev 01/16.
- Bailey TS. J Diabetes Sci Technol 2017 Jul;11(4):736-743.
- International Organization for Standardization. In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013.
- Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020.